After IPTW adjustment, OAC discontinuation was linked to a higher incidence of thromboembolism (0.86 vs. 0.37 per 100 ...
For people with atrial fibrillation (Afib or AF), stopping oral anticoagulation (OAC) after a "successful" catheter ablation ...
Triastek announces that on February 27, 2025 a proprietary 3D-printed non-vitamin K antagonist oral anticoagulant (NOAC) ...
A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for ...
Atrial Fibrillation (Afib) is a common, yet serious heart condition that requires proper diagnosis and management strategies.
It’s easy to get caught up in the noise of social media and other conversations when people have a poor experience with an establishment—and often the loudest voices are directed ...
Persistent atrial fibrillation (AFib) has long been a challenging cardiac condition to treat. Affecting millions worldwide, its complexities often stump ...
A new study from the University of Bath has found that for older adults with atrial fibrillation (AF), stopping blood ...
With no differences between single or dual antiplatelet therapy or anticoagulants at 6 months, an RCT is warranted for ...
US and European guidelines for atrial fibrillation differ in subtle but important ways that are swaying treatment decisions.
The following is a summary of “Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback